Pfizer PFE Stock
Pfizer Price Chart
Pfizer PFE Financial and Trading Overview
Pfizer stock price | 28.53 USD |
Previous Close | 39.36 USD |
Open | 39.41 USD |
Bid | 39.69 USD x 3100 |
Ask | 39.75 USD x 1000 |
Day's Range | 39.28 - 39.83 USD |
52 Week Range | 36.17 - 54.93 USD |
Volume | 19.83M USD |
Avg. Volume | 24.41M USD |
Market Cap | 224.4B USD |
Beta (5Y Monthly) | 0.589084 |
PE Ratio (TTM) | 7.840236 |
EPS (TTM) | -0.05 USD |
Forward Dividend & Yield | 1.64 (4.16%) |
Ex-Dividend Date | May 11, 2023 |
1y Target Est | 46.8 USD |
PFE Valuation Measures
Enterprise Value | 238.66B USD |
Trailing P/E | 7.840236 |
Forward P/E | 11.357142 |
PEG Ratio (5 yr expected) | -0.79 |
Price/Sales (ttm) | 2.4141865 |
Price/Book (mrq) | 2.2222846 |
Enterprise Value/Revenue | 2.568 |
Enterprise Value/EBITDA | 5.873 |
Trading Information
Pfizer Stock Price History
Beta (5Y Monthly) | 0.589084 |
52-Week Change | -14.57% |
S&P500 52-Week Change | 20.43% |
52 Week High | 54.93 USD |
52 Week Low | 36.17 USD |
50-Day Moving Average | 39.06 USD |
200-Day Moving Average | 43.9 USD |
PFE Share Statistics
Avg. Volume (3 month) | 24.41M USD |
Avg. Daily Volume (10-Days) | 21.98M USD |
Shares Outstanding | 5.65B |
Float | 5.64B |
Short Ratio | 1.81 |
% Held by Insiders | 0.034% |
% Held by Institutions | 70.67% |
Shares Short | 55.78M |
Short % of Float | 0.99% |
Short % of Shares Outstanding | 0.99% |
Dividends & Splits
Trailing Annual Dividend Rate | 1.61 |
Trailing Annual Dividend Yield | 4.09% |
5 Year Average Dividend Yield | 362.00% |
Payout Ratio | 0.3176 |
Last Split Factor | 1054:1000 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | April 2, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 31.25% |
Operating Margin (ttm) | 37.99% |
Gross Margin | 68.93% |
EBITDA Margin | 43.71% |
Management Effectiveness
Return on Assets (ttm) | 11.63% |
Return on Equity (ttm) | 31.61% |
Income Statement
Revenue (ttm) | 92.95B USD |
Revenue Per Share (ttm) | 16.56 USD |
Quarterly Revenue Growth (yoy) | -28.79% |
Gross Profit (ttm) | 66.23B USD |
EBITDA | 40.64B USD |
Net Income Avi to Common (ttm) | 29.03B USD |
Diluted EPS (ttm) | 5.07 |
Quarterly Earnings Growth (yoy) | -29.50% |
Balance Sheet
Total Cash (mrq) | 19.97B USD |
Total Cash Per Share (mrq) | 3.54 USD |
Total Debt (mrq) | 36.17B USD |
Total Debt/Equity (mrq) | 35.72 USD |
Current Ratio (mrq) | 1.37 |
Book Value Per Share (mrq) | 17.887 |
Cash Flow Statement
Operating Cash Flow (ttm) | 23.94B USD |
Levered Free Cash Flow (ttm) | 17.96B USD |
Profile of Pfizer
Country | United States |
State | NY |
City | New York |
Address | 66 Hudson Boulevard East |
ZIP | 10001-2192 |
Phone | 212 733 2323 |
Website | https://www.pfizer.com |
Industry | Drug Manufacturers-General |
Sector(s) | Healthcare |
Full Time Employees | 83000 |
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Q&A For Pfizer Stock
What is a current PFE stock price?
Pfizer PFE stock price today per share is 28.53 USD.
How to purchase Pfizer stock?
You can buy PFE shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pfizer?
The stock symbol or ticker of Pfizer is PFE.
Which industry does the Pfizer company belong to?
The Pfizer industry is Drug Manufacturers-General.
How many shares does Pfizer have in circulation?
The max supply of Pfizer shares is 5.67B.
What is Pfizer Price to Earnings Ratio (PE Ratio)?
Pfizer PE Ratio is now.
What was Pfizer earnings per share over the trailing 12 months (TTM)?
Pfizer EPS is -0.05 USD over the trailing 12 months.
Which sector does the Pfizer company belong to?
The Pfizer sector is Healthcare.
Pfizer PFE included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
S&P 500 INDEX SPX | 5308.13 USD — |
+0.09
|
1.84B USD — | — — | — — | — - | 1.84B USD — |
S&P 500 (Yahoo.com) GSPC | 5308.13 USD — |
+0.09
|
1.83B USD — | 5302.4 USD — | 5325.32 USD — | — - | 1.83B USD — |
S&P 100 SP100 | 2525.71 USD — |
+0.12
|
837.82M USD — | 2522.53 USD — | 2534.98 USD — | — - | 837.82M USD — |
Dow Jones Composite Average DJA | 12683.29 USD — |
-0.45
|
396.41M USD — | 12674.73 USD — | 12753.83 USD — | — - | 396.41M USD — |
Nasdaq Factor Family US Low Vol NQFFUSLV | 1571.73 USD — |
-0.39
|
— — | 1570.77 USD — | 1577.35 USD — | — - | — — |
NASDAQ DM Ex Japan Large Mid Ca NQDMXJPLMAUD | 2100.38 AUD 1390.15 USD |
<0.01
|
— — | 2100.38 AUD 1390.15 USD | 2100.38 AUD 1390.15 USD | — - | — — |
The Capital Strength Net Total NQCAPSTN | 3582.53 USD — |
-0.52
|
— — | 3581.1 USD — | 3598.04 USD — | — - | — — |
Nasdaq US Low Volatility Divide LVDA | 1206.1 USD — |
-0.62
|
— — | 1205.72 USD — | 1213.22 USD — | — - | — — |
Dorsey Wright Momentum Plus Div DWAMY | 1344.99 USD — |
-0.49
|
— — | 1344.99 USD — | 1344.99 USD — | — - | — — |
Better Investing 100 BIXX | 245.36 USD — |
0
|
— — | — — | — — | — - | — — |
NYSE COMPOSITE (DJ) NYA | 18335.62 USD — |
-0.29
|
— — | — — | — — | — - | — — |
Nasdaq US Price Setters Index NQPRCE | 2610.62 USD — |
-0.15
|
— — | 2608.64 USD — | 2619.08 USD — | — - | — — |
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG | 2653.43 USD — |
+0.58
|
— — | 2641.29 USD — | 2657.82 USD — | — - | — — |
Nasdaq CRD Global Sustainabilit NQCRD | 1735.62 USD — |
0
|
— — | 1715.94 USD — | 1757.95 USD — | — - | — — |
The Capital Strength Index seek NQCAPST | 3072.26 USD — |
-0.54
|
— — | 3071 USD — | 3085.56 USD — | — - | — — |
- {{ link.label }} {{link}}